TAKKT (TTK) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
11 Aug, 2026Executive summary
Organic sales declined 5.4% year-over-year in H1 2026, with stabilization and improved trends in Q2, supported by strategic portfolio streamlining and cost management.
Adjusted EBITDA margin for H1 2026 was 3.3%, with Q2 at 4.1%, reflecting effective cost actions despite lower sales and higher one-time expenses.
Free cash flow for H1 2026 was negative at EUR -9.2 million, but Q2 turned slightly positive; full-year positive free cash flow is targeted.
Portfolio simplification advanced with the sale of XXLhoreca and withdrawal from low-margin businesses, sharpening focus on core activities.
Guidance for the year was confirmed, anticipating further stabilization and improvement in H2 2026.
Financial highlights
H1 2026 sales: EUR 453.8 million, down 7.7% year-over-year; Q2 sales: EUR 228.1 million, down 4.1% organically.
Gross profit margin stable at 39.6% for H1 2026.
Adjusted EBITDA margin: 3.3% for H1 2026 (4.1% in Q2); EBITDA for H1: EUR 9.0 million.
Free cash flow for H1 2026: EUR -9.2 million, nearly unchanged from prior year.
Equity ratio at 49.5% as of June 30, 2026; net financial liabilities at EUR 133.9 million.
Outlook and guidance
Organic sales development for 2026 expected between -7% and +3%; adjusted EBITDA margin guidance set at 2% to 5%.
Gross margin for the full year anticipated between 38% and 41%.
One-time costs for the year expected to remain slightly below EUR 10 million.
Positive free cash flow targeted for the full year, with significant contribution in Q4 due to seasonality.
Gradual improvement in organic sales and profitability anticipated in H2 2026.
Latest events from TAKKT
- Operational efficiency and digital growth drive recovery amid market volatility and declining sales.TTK
Investor presentation - Sales fell 10.3% with margin pressure, but guidance and strategic focus remain unchanged.TTK
Q1 2026 - 2025 sales fell 6.6% with lower earnings, but structural gains set up margin recovery in 2026.TTK
Q4 2025 - Sales and EBITDA fell in 2025, but free cash flow stayed positive and dividend was suspended.TTK
Q4 2025 TU - Sales and profit remain under pressure, but operational fixes are driving gradual improvement.TTK
Q3 2024 - Sales and profit fell sharply in H1 2024, but cash flow and margins showed resilience.TTK
Q2 2024 - Strategy focuses on core growth, digitalization, and >10% EBITDA margin by 2028.TTK
CMD 2025 - Sales and margins declined, but guidance and cash flow outlook remain positive for 2025.TTK
Q1 2025 - Sales fell 15.4% in 2024, but strong cash flow and a EUR 0.60 dividend proposal support recovery.TTK
Q4 2024